August 2018

As part of its ongoing Neuropad guidance development, the UK National Institute of Health and Care Excellence (NICE) commissioned an Adoption Scoping Report. In the report, NICE asked NHS clinicians who were familiar with the Neuropad test what they thought of it. Amongst the comments received, the principal findings were as follows: ‘Contributors thought that sweat production is a good marker of diabetic peripheral neuropathy. All reported that Neuropad could be used as part of a comprehensive foot assessment and in conjunction with sensory testing.’ Contributors went on to say that: ‘Neuropad...